SEELEY BRUCE J. 4
4 · CTI BIOPHARMA CORP · Filed May 17, 2018
Insider Transaction Report
Form 4
SEELEY BRUCE J.
EVP, Chief Commercial Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2018-05-16+134,906→ 134,906 totalExercise: $4.14Exp: 2028-05-16→ Common Stock (134,906 underlying)
Footnotes (1)
- [F1]The stock option will vest in six equal semi-annual installments over a three-year period commencing on March 9, 2018 subject to continued employment with the Company through the applicable vesting dates, such that the option will be fully vested on March 9, 2021.